Global Obesity Treatment Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Drug Type;

Bupropion & Naltrexone, Orlistat, Lorcaserin, Phentermine & Topiramate, and Liraglutide.

By Surgery Type;

Gastric Bypass Surgery, Adjustable Gastric Banding Surgery, Gastric Sleeve Surgery, Duodenal Switch Surgery, and Others.

By Diagnosis;

Appetite Suppressants, Combination Drugs, Malabsorption, and Satiety Drugs.

By End User;

Hospitals, and Clinics.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa, and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn146758138 Published Date: January, 2025 Updated Date: February, 2025

Introduction

Global Obesity Treatment Market (USD Million), 2021 - 2031

In the year 2023, the Global Obesity Treatment Market was valued at USD 8,648.25 million. The size of this market is expected to increase to USD 22,082.56 million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of 14.3%.

Pharmaceutical treatments form a substantial segment of the market, consisting of medications that target appetite suppression, fat absorption inhibition, or metabolic regulation. These drugs are often prescribed in conjunction with lifestyle modifications to enhance effectiveness in weight management and health improvement. Surgical interventions play a crucial role, particularly for individuals with severe obesity or those who have failed to achieve significant weight loss through non-surgical means. Procedures like gastric bypass, sleeve gastrectomy, and gastric banding are designed to alter digestive processes or reduce stomach capacity, facilitating weight loss and metabolic improvements.

Medical devices also contribute to the market by providing minimally invasive options for weight management. Devices such as gastric balloons, which occupy space in the stomach to induce feelings of fullness, and neuromodulation devices, which alter nerve signals to regulate appetite and metabolism, offer alternatives to surgery for certain patient populations. Non-pharmacological approaches remain fundamental in obesity treatment, emphasizing lifestyle modifications such as dietary changes, increased physical activity, behavioral therapy, and counseling. These interventions aim not only to achieve weight loss but also to foster sustainable habits that support long-term health and well-being.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Drug Type
    2. Market Snapshot, By Surgery Type
    3. Market Snapshot, By Diagnosis
    4. Market Snapshot, By End User
    5. Market Snapshot, By Region
  4. Global Obesity Treatment Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Rising obesity rates

        2. Technological advancements

        3. Increasing healthcare spending

      2. Restraints
        1. High treatment costs

        2. Safety concerns

        3. Limited insurance coverage

      3. Opportunities
        1. Emerging markets

        2. Personalized medicine

        3. Non-surgical interventions

    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Obesity Treatment Market, By Drug Type, 2021 - 2031 (USD Million)
      1. Bupropion and Naltrexone
      2. Orlistat
      3. Lorcaserin
      4. Phentermine and Topiramate
      5. Liraglutide
    2. Global Obesity Treatment Market, By Surgery Type, 2021 - 2031 (USD Million)
      1. Gastric Bypass Surgery
      2. Adjustable Gastric Banding Surgery
      3. Gastric Sleeve Surgery
      4. Duodenal Switch Surgery
      5. Others
    3. Global Obesity Treatment Market, By Diagnosis, 2021 - 2031 (USD Million)
      1. Appetite Suppressants

      2. Combination Drugs

      3. Malabsorption

      4. Satiety Drugs

    4. Global Obesity Treatment Market, By End User, 2021 - 2031 (USD Million)
      1. Hospitals

      2. Clinics

    5. Global Obesity Treatment Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Mediflex Surgical Products
      2. Covidien plc
      3. Olympus Corporation
      4. Takeda Pharmaceuticals Company Limited
      5. Eisai Co Ltd
      6. Novo Nordisk A/S
      7. Zafgen
      8. Rhythm Pharmaceuticals
  7. Analyst Views
  8. Future Outlook of the Market